Systematic review / meta-analysis / 2017
Coffee consumption was linked to a lower risk of multiple cancers, cardiovascular disease, mortality, Parkinson's disease, and type-2 diabetes.
An umbrella review evaluated evidence from meta-analyses of observational studies and randomized controlled trials on coffee and caffeine consumption. Across 112 observational meta-analyses covering 59 unique outcomes, coffee was associated with a probable decreased risk of breast, colorectal, colon, endometrial, and prostate cancers, cardiovascular disease and mortality, Parkinson's disease, and type-2 diabetes. Across 20 observational meta-analyses covering 14 unique outcomes, caffeine was associated with a probable decreased risk of Parkinson's disease and type-2 diabetes, but an increased risk of pregnancy loss. Among 9 RCT meta-analyses examining 12 acute outcomes, coffee was associated with elevated serum lipids (affected by significant heterogeneity) and caffeine with elevated blood pressure.
Shows an association, not proof of cause and effect.
- Study type
- Umbrella review of meta-analyses of observational studies and RCTs
- Who was studied
- Participants across 112 observational meta-analyses, 20 caffeine observational meta-analyses, and 9 RCT meta-analyses
- What was measured
- Various health outcomes including cancers, cardiovascular disease, mortality, Parkinson's disease, type-2 diabetes, serum lipids, and blood pressure
THE PAPER
Coffee, Caffeine, and Health Outcomes: An Umbrella Review.
Grosso G, Godos J, Galvano F, Giovannucci EL. Annu Rev Nutr, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.